Clinart MENA

Clinart MENA is an innovative, full-service clinical research organization, complementing pharmaceutical, biotechnology, and medical device companies in their endeavor to bring emerging drugs to market. Headquartered in Dubai, United Arab Emirates, ClinArt International has been serving the Middle East with offices in Dubai, Cairo, and Riyadh, giving instant access to a population of 150 million largely unexposed to clinical trials: Egypt, KSA, UAE, Kuwait, Qatar, Bahrain, Oman, Jordan, Lebanon, Algeria, Tunisia, and Morocco. Founded in 2008, Clinart MENA operates in the industries of Biotechnology, Health Care, and Pharmaceutical.

Despite a lack of specific information about the last investment and investors, Clinart MENA’s strategic location in the Middle East, its focus on expanding access to clinical trials, and commitment to innovative research present compelling opportunities for investment. As the company is now a part of CTI, it will be interesting to observe how this integration drives further growth and impact in the region’s healthcare and pharmaceutical sectors.